Structural engineering of a phage lysin that targets Gram-negative pathogens.
Lukacik, P., Barnard, T.J., Keller, P.W., Chaturvedi, K.S., Seddiki, N., Fairman, J.W., Noinaj, N., Kirby, T.L., Henderson, J.P., Steven, A.C., Hinnebusch, B.J., Buchanan, S.K.(2012) Proc Natl Acad Sci U S A 109: 9857-9862
- PubMed: 22679291 
- DOI: 10.1073/pnas.1203472109
- Primary Citation of Related Structures:  
4EPA, 4EPF, 4EPI, 4EXM - PubMed Abstract: 
Bacterial pathogens are becoming increasingly resistant to antibiotics. As an alternative therapeutic strategy, phage therapy reagents containing purified viral lysins have been developed against gram-positive organisms but not against gram-negative organisms due to the inability of these types of drugs to cross the bacterial outer membrane ...